Deciphera
4 known investors
Find your way into Deciphera
134 people in our graph share verified history with the Deciphera team — schools, employers, funds. One of them is your warm intro.
Michael Taylorunlockedknows Daniel Flynn · together at Deciphera (overlapped)
×11knows the team · via The University of Kansas
Deciphera is a pharmaceutical company focused on developing treatments for people living with cancer. Its work centers on oncology drug development and support for patient communities.
Founders & leadership
DF
Daniel FlynninFounder and Chief Scientific Officer, Retired2003–2023Daniel Flynn is founder and former chief scientific officer of Deciphera Pharmaceuticals, where he led development of multiple oncology therapeutics including ripretinib, vimseltinib, and altiratinib. He has held positions in medicinal chemistry and drug design at Amgen, Millennium Pharmaceuticals, and other pharmaceutical firms, and serves as an adjunct professor of medicinal chemistry at the University of Kansas.
Investors · 4
In the news
Frequently asked questions
- What does Deciphera do?
- Deciphera is a pharmaceutical company focused on developing treatments for people living with cancer. Its work centers on oncology drug development and support for patient communities.
- Who founded Deciphera?
- Deciphera was founded by Daniel Flynn.
- Who are Deciphera's investors?
- Deciphera's investors include Frazier Life Sciences, New Leaf Venture Partners, REDMILE, Viking Global Investors.